15 articles with Yale University
Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)
Biofourmis' innovative technology to measure patient-centric endpoints to inform future drug development
Tiziana Life Science reports Independent Third Party Article in New England Journal of Medicine on Intravenous Treatment with a Humanized Anti-CD3 mAb showing delays in progression of Type 1 Diabetes
Independent third party Phase 2 results show Teplizumab, a mouse derived humanized anti-CD3 monoclonal antibody (mAb) significantly slowed progression of Type 1 diabetes in high risk population
Scholarly publishing tech provider, HighWire, announced it is proud to support the founders of medRxiv, by providing the hosting and submissions technology that underpins the new preprint server.
December 14 Research Roundup: Lonesome George’s Genome, Alzheimer’s and Prostate Cancer Tests and...
12/14/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage
Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced it has entered into a collaboration agreement with the Paul Turner Lab at Yale University to manufacture and supply therapeutic bacteriophage (phage) for use in clinical trials.
It seems like every time we turned around this year, there was an exciting or—on a more visceral level, “Hey, that’s cool!” science story. Here’s a look at the top 9 really cool life science discoveries of the year, from outer space, to peanut allergies, to tortoise genomes.
12/11/2018Researchers published an article in the journal Nature Ecology & Evolution that described preliminary findings of gene variants in George associated with a strong immune system, efficient DNA repair and cancer resistance.
Collaboration aims to accelerate the development and translation of Yale's research and innovation projects to a decision point.
Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.
BlackThorn Therapeutics Announces Exclusive Licensing Agreement and Extension of Key Collaboration With Yale University
First Publication Emerges from Company’s Multi-year Research Collaboration with Yale’s Division of Neurocognition, Neurocomputation, and Neurogenetics
July 13 Research Roundup: Gene Therapy for Cholesterol, Beta-Thalassemia, and Kidney Disease, and...
7/13/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them from gene therapy for cholesterol to kidney disease and more.
Educational institutions, even at the high school level, are creating specialized biotechnology training programs to satisfy the growth they see within the biotech industry.
A research group at Yale University and from Hanyang University, South Korea, developed a new RNA therapy for West Nile Virus. The findings, which were studied in mice, was published in Cell Host & Microbe.
Enigma Biomedical Group and Yale Sign Memorandum of Understanding to License Novel Investigational Synaptic Density Imaging Biomarker Technology
Understanding to License Novel Investigational Synaptic Density Imaging Biomarker Technology
Patrys Limited is pleased to announce further pre-clinical data for its drug candidate PATDX1-NP.